In this episode of “Intention to Treat,” Drs. Harvey Fineberg and Eric Rubin take stock of the failures and successes of the Covid-19 response and elucidate their lessons for combating the next major public health threat, whatever it may be.
A full transcript of this episode is available at nejm.org/doi/full/10.1056/NEJMp2303615.
Jul 2023
The Plight of Primary Care, Part 1
This episode of “Intention to Treat,” explores the crisis in primary care in the United States, as increasing numbers or primary care physicians leave the field — driven out by corporatization, growing time pressure, and the inability to form the relationships that enable good ca ... Show More
54m 55s
Jan 2023
What Promise Do Psychedelics Hold As Therapeutics?
When psychedelics were first studied more than 50 years ago, researchers noticed that they were useful in helping people explore a greater sense of self. Now, after a half-century hiatus, scientists are studying psychedelics like MDMA, psilocybin, and ketamine as treatment for de ... Show More
34m 17s
Jul 2025
Essentials: Psychedelics for Treating Mental Disorders | Dr. Matthew Johnson
In this Huberman Lab Essentials episode, my guest is Dr. Matthew Johnson, PhD, a senior researcher for the Center of Excellence for Psilocybin Research and Treatment at Sheppard Pratt’s Institute for Advanced Diagnostics and Therapeutics. We explore the science and therapeutic po ... Show More
39m 9s
Nov 2022
What Promise Do Psychedelics Hold As Therapeutics?
When psychedelics were first studied more than 50 years ago, researchers noticed that they were useful in helping people explore a greater sense of self. Now, after a half-century hiatus, scientists are studying psychedelics like MDMA, psilocybin, and ketamine as treatment for de ... Show More
33m 13s